Frontiers in Neurology· 2012Q2
Behavioral and Psychological Symptoms of Dementia
- 1,399citations
- Q2SCImago
- 2012year
Short summary
Behavioral and psychological symptoms of dementia (BPSD), affecting up to 90% of patients, are as clinically relevant as cognitive symptoms and independently linked to poor outcomes like patient/caregiver distress and increased healthcare costs.
AI-generated from the title and abstract; the full text is not read.
Key points
- BPSD affect up to 90% of dementia patients and are a major component of the syndrome.
- BPSD are clinically as relevant as cognitive symptoms and correlate with functional impairment.
- BPSD are independently associated with poor outcomes, including patient/caregiver distress and increased healthcare costs.
- Effective management requires a combination of non-pharmacological and pharmacological strategies.
- There is an urgent need for novel therapeutic targets and approaches for BPSD.
AI-generated from the title and abstract; the full text is not read.
Abstract
Behavioral and psychological symptoms of dementia (BPSD), also known as neuropsychiatric symptoms, represent a heterogeneous group of non-cognitive symptoms and behaviors occurring in subjects with dementia. BPSD constitute a major component of the dementia syndrome irrespective of its subtype. They are as clinically relevant as cognitive symptoms as they strongly correlate with the degree of functional and cognitive impairment. BPSD include agitation, aberrant motor behavior, anxiety, elation, irritability, depression, apathy, disinhibition, delusions, hallucinations, and sleep or appetite changes. It is estimated that BPSD affect up to 90% of all dementia subjects over the course of their illness, and is independently associated with poor outcomes, including distress among patients and caregivers, long-term hospitalization, misuse of medication, and increased health care costs. Although these symptoms can be present individually it is more common that various psychopathological features co-occur simultaneously in the same patient. Thus, categorization of BPSD in clusters taking into account their natural course, prognosis, and treatment response may be useful in the clinical practice. The pathogenesis of BPSD has not been clearly delineated but it is probably the result of a complex interplay of psychological, social, and biological factors. Recent studies have emphasized the role of neurochemical, neuropathological, and genetic factors underlying the clinical manifestations of BPSD. A high degree of clinical expertise is crucial to appropriately recognize and manage the neuropsychiatric symptoms in a patient with dementia. Combination of non-pharmacological and careful use of pharmacological interventions is the recommended therapeutic for managing BPSD. Given the modest efficacy of current strategies, there is an urgent need to identify novel pharmacological targets and develop new non-pharmacological approaches to improve the adverse outcomes associated with BPSD.
The authors' abstract, as published at the source. Frontiers in Neurology, 2012 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Psychiatry and Mental health
Psychiatry and Mental healthMedicine